BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 8287348)

  • 1. Physicians and the pharmaceutical industry (update 1994). Canadian Medical Association.
    CMAJ; 1994 Jan; 150(2):256A-256F. PubMed ID: 8287348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMA issues revised guidelines on physicians' relationship with pharmaceutical industry.
    Williams JR
    CMAJ; 1994 Jan; 150(2):263, 265. PubMed ID: 8287352
    [No Abstract]   [Full Text] [Related]  

  • 3. Approaches to enhancing the quality of drug therapy. A joint statement by the CMA and the Canadian Pharmaceutical Association. Canadian Medical Association.
    CMAJ; 1996 Sep; 155(6):784A-784F. PubMed ID: 8823225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The ANMCO (National Association of Hospital Cardiologists) in a changing health care system. Consensus development of the Organizing Symposium of the XXXI National Congress of Cardiology--ANMCO; Florence, May 21, 2000].
    Ital Heart J Suppl; 2000 Dec; 1(12):1533-44. PubMed ID: 11221582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
    Williams JR
    CMAJ; 1993 Aug; 149(3):335-7. PubMed ID: 11659649
    [No Abstract]   [Full Text] [Related]  

  • 6. The physician's relationship with the pharmaceutical industry: caveat emptor...buyer beware!
    Albersheim SG; Golan A
    Isr Med Assoc J; 2011 Jul; 13(7):389-93. PubMed ID: 21838178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMA leads drive to improve physicians' management skills.
    Wharry S
    CMAJ; 1997 Feb; 156(3):409-10. PubMed ID: 9033427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMA guidelines on MD-drug industry relations part of international trend.
    Williams JR
    CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902
    [No Abstract]   [Full Text] [Related]  

  • 12. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Canadian Medical Association Code of Ethics 1868 to 1996: a primer for medical educators.
    Brownell AK; Brownell E
    Ann R Coll Physicians Surg Can; 2002 Jun; 35(4):240-243. PubMed ID: 14982086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
    Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
    Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
    [No Abstract]   [Full Text] [Related]  

  • 15. Physicians and the pharmaceutical industry.
    Canadian Medical Association
    CMAJ; 1992 Feb; 146(3):388A-C. PubMed ID: 11654903
    [No Abstract]   [Full Text] [Related]  

  • 16. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuing medical education: ethical collaboration between sponsor and industry.
    Wilson FS
    Clin Orthop Relat Res; 2003 Jul; (412):33-7. PubMed ID: 12838049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians and the pharmaceutical industry (update 2001).
    Canadian Medical Association
    CMAJ; 2001 May; 164(9):1339-44. PubMed ID: 11341156
    [No Abstract]   [Full Text] [Related]  

  • 20. Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
    Zoorob R; Larzelere M
    J La State Med Soc; 2004; 156(1):28-32. PubMed ID: 15000210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.